AU9002798A - Fused or nonfused benzene compounds - Google Patents

Fused or nonfused benzene compounds

Info

Publication number
AU9002798A
AU9002798A AU90027/98A AU9002798A AU9002798A AU 9002798 A AU9002798 A AU 9002798A AU 90027/98 A AU90027/98 A AU 90027/98A AU 9002798 A AU9002798 A AU 9002798A AU 9002798 A AU9002798 A AU 9002798A
Authority
AU
Australia
Prior art keywords
nonfused
fused
benzene compounds
benzene
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU90027/98A
Inventor
Daikichi Fukushima
Yoshisuke Nakayama
Hisao Tajima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ono Pharmaceutical Co Ltd
Original Assignee
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co Ltd filed Critical Ono Pharmaceutical Co Ltd
Publication of AU9002798A publication Critical patent/AU9002798A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
AU90027/98A 1997-09-19 1998-09-11 Fused or nonfused benzene compounds Abandoned AU9002798A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP25578797 1997-09-19
JP9-255787 1997-09-19
PCT/JP1998/004116 WO1999015520A1 (en) 1997-09-19 1998-09-11 Fused or nonfused benzene compounds

Publications (1)

Publication Number Publication Date
AU9002798A true AU9002798A (en) 1999-04-12

Family

ID=17283634

Family Applications (1)

Application Number Title Priority Date Filing Date
AU90027/98A Abandoned AU9002798A (en) 1997-09-19 1998-09-11 Fused or nonfused benzene compounds

Country Status (2)

Country Link
AU (1) AU9002798A (en)
WO (1) WO1999015520A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL145922A0 (en) 1999-04-28 2002-07-25 Aventis Pharma Gmbh Di-aryl acid derivatives as ppar receptor ligands
US6436993B1 (en) 1999-07-13 2002-08-20 The Salk Institute For Biological Studies Use of RAR antagonists as modulators of hormone mediated processes
TWI302149B (en) 1999-09-22 2008-10-21 Bristol Myers Squibb Co Substituted acid derivatives useful as antiodiabetic and antiobesity agents and method
US6414002B1 (en) 1999-09-22 2002-07-02 Bristol-Myers Squibb Company Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
EP1911462A3 (en) 2001-01-26 2011-11-30 Schering Corporation Compositions comprising a sterol absorption inhibitor
EP1405848B1 (en) 2001-06-18 2008-05-07 Ono Pharmaceutical Co., Ltd. Tetrahydroquinoline derivative compound and drug containing the compound as active ingredient
PL374860A1 (en) 2002-07-09 2005-11-14 Bristol-Myers Squibb Company Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
EP2305352A1 (en) 2004-04-02 2011-04-06 Merck Sharp & Dohme Corp. 5-alpha-reductase inhibitors for use in the treatment of men with metabolic and anthropometric disorders
CA2568766A1 (en) 2004-05-29 2005-12-08 7Tm Pharma A/S Crth2 receptor ligands for medicinal uses
ITRM20050389A1 (en) * 2005-07-22 2007-01-23 Giuliani Spa COMPOUNDS AND THEIR SPECIFIC SALTS FOR PPAR RECEPTORS AND RECEPTORS FOR EGF AND THEIR USE IN MEDICAL FIELDS.
ITRM20050390A1 (en) * 2005-07-22 2007-01-23 Giuliani Spa COMPOUNDS AND THEIR SPECIFIC SALTS FOR PPAR RECEPTORS AND RECEPTORS FOR EGF AND THEIR USE IN MEDICAL FIELDS.
UA107562C2 (en) 2008-12-05 2015-01-26 METHOD OF TREATMENT OF PSORIASIS
JP5715070B2 (en) 2009-02-16 2015-05-07 ノグラ ファーマ リミテッド Alkylamide compounds and uses thereof
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
US9682923B2 (en) 2012-02-09 2017-06-20 Nogra Pharma Limited Methods of treating fibrosis
CN104284655B (en) 2012-04-18 2017-10-27 诺格拉制药有限公司 The method for treating lactose intolerance
KR20210125047A (en) 2019-02-08 2021-10-15 노그라 파마 리미티드 Process for the preparation of 3-(4'-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4202818A (en) * 1978-10-16 1980-05-13 Shell Oil Company Lipogenesis inhibition by certain esters of substituted benzodioxincarboxylic acids
JPS6150977A (en) * 1984-08-20 1986-03-13 Ono Pharmaceut Co Ltd Novel condensed benz(thio)amide, preparation thereof and pharmaceutical containing same as active constituent
JPS61118380A (en) * 1984-11-14 1986-06-05 Shionogi & Co Ltd Novel 1,4-benzodioxane and 1,4-benzodioxine derivative and preparation thereof
IL101785A0 (en) * 1991-05-10 1992-12-30 Fujisawa Pharmaceutical Co Urea derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
WO1999015520A1 (en) 1999-04-01

Similar Documents

Publication Publication Date Title
AU7210598A (en) Novel compounds
AU6804098A (en) Triazinylaminostilbene compounds
ZA985323B (en) New compounds
AU9002798A (en) Fused or nonfused benzene compounds
AU8872198A (en) Aminometyl oxooxazolidinyl benzene derivatives
AUPP003197A0 (en) New heterocyclic compounds
GB2345910B (en) Photochromic compounds
AU3899097A (en) Substituted aromatic compounds
AU4925697A (en) Compounds
AU9066598A (en) Substituted 4-benzoyl-pyrazoles
AU7476598A (en) 18-substituted-19-nor-vitamin d compounds
AU6422098A (en) Benzene derivatives
AU6747498A (en) Benzene derivatives
AUPO941497A0 (en) Novel compounds
AU7124598A (en) Polymer-platinum compounds
AUPP042397A0 (en) 5-arylpyrazole compounds
ZA989839B (en) New spirocyciic compounds
GB9512479D0 (en) Substituted benzene derivatives
ZA983736B (en) New compounds
AUPO622597A0 (en) New heterocyclic compounds
AU8019998A (en) Fluoromethoximino compounds
AU6090898A (en) Substituted 4-benzoyl-pyrazoles
GB9713732D0 (en) Substituted triazinic compounds
AUPP003297A0 (en) 4,5-diaryloxazole compounds
AUPO691897A0 (en) New compound

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase